Skip to main content
Future Journal of Pharmaceutical Sciences
Fig. 5 | Future Journal of Pharmaceutical Sciences

Fig. 5

From: Octreotide (somatostatin analog) attenuates cardiac ischemia/reperfusion injury via activating nuclear factor (erythroid-derived 2)-like 2 (Nrf2) signaling pathway in rat model of hyperthyroidism

Fig. 5

Effect of octreotide on Nrf2-regulated gene expressions of HO-1 (a), SOD (b), GPx (c), and catalase (d) in rat hearts exposed to ischemia for 30 min and reperfusion for 120 min. Data are represented as mean ± standard deviation. Significance (P < 0.05): *significant when compared with the control group, #significant when compared with HTC group, $significant when compared with HT+OCT

Back to article page